Wells Fargo’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
25,571
+3,138
| +14% | +$137K | ﹤0.01% | 3288 |
|
|
2025
Q1 | $614K | Buy |
22,433
+494
| +2% | +$13.5K | ﹤0.01% | 3539 |
|
|
2024
Q4 | $883K | Buy |
21,939
+7,487
| +52% | +$301K | ﹤0.01% | 3348 |
|
|
2024
Q3 | $684K | Buy |
14,452
+73
| +0.5% | +$3.46K | ﹤0.01% | 3442 |
|
|
2024
Q2 | $429K | Buy |
14,379
+1,321
| +10% | +$39.4K | ﹤0.01% | 3671 |
|
|
2024
Q1 | $525K | Buy |
13,058
+2,268
| +21% | +$91.2K | ﹤0.01% | 3513 |
|
|
2023
Q4 | $275K | Sell |
10,790
-25,483
| -70% | -$649K | ﹤0.01% | 3895 |
|
|
2023
Q3 | $504K | Sell |
36,273
-16,888
| -32% | -$235K | ﹤0.01% | 3508 |
|
|
2023
Q2 | $1.22M | Buy |
53,161
+10,884
| +26% | +$250K | ﹤0.01% | 3143 |
|
|
2023
Q1 | $1.25M | Buy |
42,277
+40,240
| +1,975% | +$1.19M | ﹤0.01% | 3020 |
|
|
2022
Q4 | $50.8K | Sell |
2,037
-1,470
| -42% | -$36.7K | ﹤0.01% | 4546 |
|
|
2022
Q3 | $77K | Sell |
3,507
-5,656
| -62% | -$124K | ﹤0.01% | 4448 |
|
|
2022
Q2 | $180K | Sell |
9,163
-9,304
| -50% | -$183K | ﹤0.01% | 4086 |
|
|
2022
Q1 | $782K | Sell |
18,467
-10,899
| -37% | -$462K | ﹤0.01% | 3840 |
|
|
2021
Q4 | $1.87M | Sell |
29,366
-6,116
| -17% | -$388K | ﹤0.01% | 3354 |
|
|
2021
Q3 | $2.08M | Buy |
35,482
+34,052
| +2,381% | +$2M | ﹤0.01% | 3459 |
|
|
2021
Q2 | $69K | Buy |
1,430
+541
| +61% | +$26.1K | ﹤0.01% | 5125 |
|
|
2021
Q1 | $34K | Sell |
889
-9,898
| -92% | -$379K | ﹤0.01% | 5636 |
|
|
2020
Q4 | $669K | Buy |
+10,787
| New | +$669K | ﹤0.01% | 4239 |
|